Abstract
The level of β-galactoside α2,6sialyltransferase I (ST6Gal I) mRNA, encoded by the gene siat1, is increased in malignant tissues. Expression is regulated by different promoters – P1, P2 and P3 – generating three mRNA isoforms H, X and YZ. In cervical cancer tissue the mRNA isoform H, which results from P1 promoter activity, is increased. To study the regulation of P1 promoter, different constructs from P1 promoter were evaluated by luciferase assays in cervical and hepatic cell lines. Deletion of a fragment of 1048 bp (−89 to +24 bp) increased 5- and 3-fold the promoter activity in C33A and HepG2 cell lines, respectively. The minimal region with promoter activity was a 37 bp fragment in C33A cells. The activity of this region does not require the presence of an initiator sequence. In HepG2 cells the minimal promoter activity was detected in the 66 bp fragment. Sp1 (−32) mutation increased the promoter activity only in HepG2 cells. HNF1 mutation decreased promoter activity in HepG2 cell line but not in C33A cells. We identified a large region that plays a negative regulation role. The regulation of promoter activity is cell type specific. Our study provides new insights into the complex transcriptional regulation of siat1 gene.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aaas-Eng DA, Asheim, HC, Deggerdal A, Smeland E and Funderud S 1995 Characterization of a promoter region supporting transcription of a novel human-beta galactoside alpha-2,6-sialyltransferase transcript in HepG2 cells. Biochim. Biophys. Acta 1261 166–169
Aasheim HC, Aas-Enh DA, Deggerdal A, Blomhoff HK, Funderud S and Smeland EB 1993 Cell-specific expression of human beta-galactoside α2,6sialyltransferase transcripts differing in the 5′untranslated region. Eur. J. Biochem. 213 467–475
Dall’Olio F 1996 Protein glycosylation in cancer biology: an overview. Clin. Mol. Pathol. 49 126M-135M
Dall’Olio F, Chiricolo M, Ceccarelli C, Minni F, Marrano D and Santini D 2000 Beta galactoside alpha2,5 sialyltransferase in human colon cancer: contribution of multiple transcripts to regulation of enzyme activity and reactivity with Sambucus nigra agglutinin. Int. J. Cancer 88 58–65
Deng Z, Cao P, Wan M and Sui G 2010 Yin Yang 1 A multifaceted protein beyond a transcription factor. Transcription 1 81–84
Dittmer J 2003 The biology of the ets1 proto-oncogene. Mol. Cancer 2 1–21
Furlong EM, Rein T and Martin F 1996 YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity. Mol. Cell Biol. 16 5933–5945
Gardner L, Lee L and Dang D 2002 The c-Myc oncogenic transcription factor; in Encyclopedia of Cancer (ed) J Bertino (San Diego CA Academic Press) pp 555–561
Harduin-Lepers A, Vallejo-Ruiz V, Krzewinski-Recchi MA, Samyn-Petit B, Julien S, Delannoy P 2001 The human sialyltransferases family. Biochimie 83 727–737
Kato H, Horikoshi M and Roeder RG 1991 Repression of HIV-1 transcription by a cellular protein. Science 251 1476–1479
Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M, Ariga H and Inoue M 2000 Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res. 28 669–677
Lee JA, Suh DC, Kang JE, Kim MH, Park H, Lee MN, Kim JM, Jeon BN, et al. 2005 Transcriptional activity of Sp1 is regulated by molecular interactions between the zinc finger DNA binding domain and the inhibitory domain with corepressors, and this interaction is modulated by MEK. J. Biol. Chem. 280 28061–28071
Lo NW and Lau JTY 1996a Novel heterogeneity exists in the 5′-untranslated region of the β-galactoside α2,6-sialyltransferase mRNAs in the human B-lymphoblastoid cell line, Louckes. Biochem. Biophys. Res. Commun. 228 380–385
Lo NW and Lau JTY 1996b Transcription of the beta-galactoside alpha2,6-sialyltransferase gene in B lymphocytes is directed by a separate and distinct promoter. Glycobiology 6 271–279
López-Morales D, Velázquez-Márquez N, Valenzuela O, Santos-López G, Reyes-Leyva J and Vallejo-Ruiz V 2009 Enhanced sialyltransferases transcription in cervical intraepithelial neoplasia. Invest. Clin. 50 45–53
Luke MP, Sui G, Liu H and Shi Y 1996 Yin YangI physically interacts with HOXA11 and represses HOXA11-dependent transcription. J. Biol.Chem. 281 33226–33232
Manzano-Winkler M, Novina CD and Roy AL 1996 TFII is required for transcription of the naturally TATA-less but initiator-containing Vβ promoter. J. Biol. Chem. 271 12076–12081
Meany DL and Chan DW 2011 Aberrant glycosylation associated with enzymes as cancer biomarkers. Clin. Proteom. 8 1–14
Peters B, Merezhinskaya N, Diffley JF and Noguchi CT 1993 Protein-DNA interactions in the globin gene silencer. J. Biol. Chem. 268 3430–3437
Rezai-Zadeh N, Zhang X, Namour F, Fejer G, Wen YD, Yao YL, Gyory I, Wright K and Seto E 2003 Targeted recruitment of a histone H4-specific methyltransferase by the transcription factor YY1. Genes Dev. 17 1019–1029
Shea-Eaton W, Lopez D and McLean M 2001 Yin Yang 1 protein negatively regulates high-density lipoprotein receptor gene transcription by disrupting binding of sterol regulatory element binding protein to sterol regulatory element. Endocrinology 142 49–58
Shrivastaval A and Calamel K 1994 An analysis of genes regulated by the multi-functional transcriptional regulator Yin Yang-1. Nucleic Acids Res. 22 5151–5155
Smale ST and Baltimore D 1989 The "initiator" as a transcription control element. Cell 57 103–113
Stamenkovic I, Asheim HC, Deggerdal A, Blomhoff HK, Smeland EB and Funderud S 1990 The B cell antigen CD75 is a cell surface sialyltransferase. J. Exp. Med. 172 641–643
Svensson EC, Conley PB, Paulson JC 1992 Regulated expression of α2,6-sialyltransferase by the liver-enriched transcription factors HNF- 1, DBP, and LAP. J. Biol. Chem. 267 3466–3472
Wang PH, Li YF, Juang CM, Lee YR, Chao HT, Ng HT, Tsai YC and Yuan CC 2002 Expression of sialyltransferase family members in cervix squamous cell carcinoma correlates with lymph node metastasis. Gynecol. Oncol. 86 45–52
Wang PH, Lee WL, Lee YR, JuangCh M, Chen YJ, Chao HT, Tsai YCH and Yuan CC 2003 Enhaced expression of α2,6-sialyltransferase ST6gal I in cervical squamous cell carcinoma. Gynecol. Oncol. 89 395–401
Wang XC, O’Hanlon TP, Young RF and Lau JTY 1990 Rat beta-galactoside alpha 2,6-sialyltransferase genomic organization: alternate promoters direct the synthesis of liver and kidney transcripts. Glycobiology 1 25–31
Wang XC, Vertino A, Eddy RL, Byers MG, Jani-Sait SN, Shows TB and Lau JT 1993 Chromosome mapping and organization of the human β-galactoside α2,6-sialyltransferase gene. Differential and cell-type specific usage of upstream exon sequences in B-lymphoblastoid cells. J. Biol. Chem. 268 4355–4361
Xu L, Kurusu Y, Takizawa K, Tabaka J, Matsumoto K and Taniguchi A 2003 Transcriptional regulation of human β-galactosideα2,6-sialyltransferase (hST6Gal I) gene in colon adenocarcinoma cell line. Biochem. Biophys. Res. Commun. 307 1070–1074
Acknowledgements
This work was supported by grants FIS/IMSS/PROT/MD10/865 from the Instituto Mexicano del Seguro Social (IMSS). LMF was the recipient of a scholarship from CONACyT (47337) and IMSS (99227051), México.
Author information
Authors and Affiliations
Corresponding author
Additional information
[Milflores-Flores L, Millán-Pérez L, Santos-López G, Reyes-Leyva J and Vallejo-Ruiz V 2012 Characterization of P1 promoter activity of the β-galactoside α2,6sialyltransferase I gene (siat 1) in cervical and hepatic cancer cell lines. J. Biosci. 37 1–8] DOI
Rights and permissions
About this article
Cite this article
Milflores-Flores, L., Millán-Pérez, L., Santos-López, G. et al. Characterization of P1 promoter activity of the β-galactoside α2,6sialyltransferase I gene (siat 1) in cervical and hepatic cancer cell lines. J Biosci 37, 259–267 (2012). https://doi.org/10.1007/s12038-012-9194-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12038-012-9194-6